Peptides/Nanomedicine for AS

Using biocompatible and biodegradable peptides in nanomedicine for atherosclerosis provides targeting and therapeutic functionality that can assist in overcoming delivery barriers of traditional drugs and makes them attractive for in vivo use. Here is the latest research.

May 23, 2020

IL-6 promotes cell adhesion in human endothelial cells via microRNA-126-3p suppression

Experimental Cell Research
Momoka OhtaMineyoshi Aoyama
May 16, 2020

Roles of the kisspeptin/GPR54 system in pathomechanisms of atherosclerosis

Nutrition, Metabolism, and Cardiovascular Diseases : NMCD
Takuya Watanabe, Kengo Sato
May 20, 2020
Open Access

Selective role of Nck1 in atherogenic inflammation and plaque formation

The Journal of Clinical Investigation
Mabruka AlfaidiA Wayne Orr
May 28, 2020

Application of targeted therapy strategies with nanomedicine delivery for atherosclerosis

Acta Pharmacologica Sinica
Le-Chun OuJin-Wei Tian
May 27, 2020

Oxidized LDL induces vimentin secretion by macrophages and contributes to atherosclerotic inflammation

Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte
SeoYeon KimYoung Mi Park
May 28, 2020

Colorimetric detection of miRNA-21 by DNAzyme-coupled branched DNA constructs

Elyas HosseinzadehHossein Pourghadamyari
May 29, 2020
Open Access

Colchicine's effects on metabolic and inflammatory molecules in adults with obesity and metabolic syndrome: results from a pilot randomized controlled trial

International Journal of Obesity : Journal of the International Association for the Study of Obesity
Andrew P DemidowichJack A Yanovski
May 28, 2020
Open Access

Graphene Oxide Nanosheets Tailored With Aromatic Dipeptide Nanoassemblies for a Tuneable Interaction With Cell Membranes

Frontiers in Bioengineering and Biotechnology
Giuseppe TrapaniCristina Satriano
May 20, 2020

Targeting Dysfunctional Vascular Endothelial Cells Using Immunoliposomes Under Flow Conditions

Cellular and Molecular Bioengineering
Mahsa KheradmandiAmir M Farnoud
May 28, 2020

Biomimetic oral targeted delivery of bindarit for immunotherapy of atherosclerosis

Biomaterials Science
Luqi YinXiaohui Li
May 27, 2020

A Dodecapeptide Selected by Phage Display as a Potential Theranostic Probe for Colon Cancers

Translational Oncology
Moon Hwa KwakJae Myung Park
May 20, 2020
Open Access

Assessment of a pro-healing stent in an animal model of early neoatherosclerosis

Scientific Reports
Philipp NicolMichael Joner

Sign up to follow this feed and discover related papers.

Related Feeds

Adult Kidney Organoids at Single Cell Resolution

Single-cell RNA sequencing of the adult human kidney transcriptome can provide molecular information about cell-specific responses to environmental variables and disease states. This information can provide a dataset to benchmark human kidney organoids. Discover the latest research on adult kidney organoids at single cell resolution here.

Artificial Cell Models

This feed focuses on biomimetrics, synthetic biology and bio- and tissue-engineering approaches used for modeling human diseases.

Artificial Heart & Ventricular Assist Devices

Total artificial hearts (TAH) and ventricular assist devices (VADs) provide cardiac support for patients with end-stage heart disease and have significantly improved the survival of these patients. Discover the latest research on Artificial Heart and Ventricular Assist Devices here.

Biomaterial Engineering

Advances in biomaterial engineering have permitted the development of sophisticated drug-releasing materials with a biomimetic 3D support that allow a better control of the microenvironment of transplanted cells. Here is the latest research.

Brain Organoids in Disease Modeling

Brain organoids are used to represent an in vitro model of the human brain. These brain organoids are derived from three-dimensional human pluripotent stem cells and can be used to help study brain biology, early brain development and different brain diseases. Discover the latest research on brain organoids in disease modeling here.

CFTR Mutant Structural Therapy

Over 1700 different mutations in the CFTR genes have been shown to cause cystic fibrosis. Here is the latest research on structural therapy for CFTR mutants.

CRISPR Genome Editing & Therapy

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of this system for gene editing and therapy in human diseases.

CRISPR for Genome Editing

Genome editing technologies enable the editing of genes to create or correct mutations. Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). Here is the latest research on the use of CRISPR-Cas system in gene editing.

CRISPR in Malaria

CRISPR-Cas system enables the editing of genes to create or correct mutations. This technology is being investigated to combat malaria by targeting specific stretches of vector DNA and editing the genome at precise locations. Here is the latest research.

Cancer Cell Invasion: Nanomedicine

Nanomedicine is a promising alternative for cancer detection and therapy that utilizes nanoparticles, such as liposomes. Nanoparticles can potentially target cancer cell invasion and metastasis. Discover the latest research on Cancer Cell Invasion: Nanomedicine here.

© 2020 Meta ULC. All rights reserved